Further analyses of the tumor samples with immunohistochemical (IHC) suggested that E2F1 staining intensity decreased when miR-338-3p and miR-362-3p binding sites were both mutated, in comparison with wild-type SBF2-AS1 (Figure 6B). The gene discussed is SBF2; the disease is neoplasm.